The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study
Open Access
- 1 January 2012
- journal article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 11 (1) , 77
Abstract
The metabolic syndrome (MetS) is associated with increased risk of cardiovascular disease. In this study, we examine if metabolic syndrome predicts progression of atherosclerosis over 13 years.Keywords
This publication has 28 references indexed in Scilit:
- Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetesCardiovascular Diabetology, 2011
- Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetesCardiovascular Diabetology, 2011
- The metabolic syndromeThe Lancet, 2010
- Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young AdultsCirculation, 2009
- Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø studyJournal of Thrombosis and Haemostasis, 2009
- Metabolic syndrome and carotid intima media thickness in the Health 2000 SurveyAtherosclerosis, 2009
- Recent advances in metabolic syndrome and cardiovascular diseaseArchives of Cardiovascular Diseases, 2008
- Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC studyInternational Journal of Obesity, 2008
- Adipose Tissue and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- The Metabolic Syndrome and Subclinical Carotid Atherosclerosis: The Northern Manhattan StudyJournal of the CardioMetabolic Syndrome, 2007